Assoc. Prof. Dr. Farihahusnah Hussin | Life Science Engineering & Nanobiotech | Research Excellence Award

Published on 02/12/202512/12/2025 by Life Science

Assoc. Prof. Dr. Farihahusnah Hussin | Life Science Engineering & Nanobiotech | Research Excellence Award

Farihahusnah Hussin, Senior Research Fellow, Sunway University | Malaysia

Assoc. Prof. Ts. Dr. Farihahusnah Hussin is a chemical engineering researcher specializing in sustainable carbon capture, separation processes, and waste-to-resource technologies. She earned her PhD and MEng.Sc in Chemical Engineering from the University of Malaya and has built an impactful academic career at Sunway University, where she has served as Research Fellow, Senior Research Fellow, and currently Associate Professor at the Faculty of Engineering and Technology. Her research explores CO₂ capture and utilisation, biomass valorisation, activated carbon functionalisation, electrochemical conversion, life-cycle assessment, and machine learning applications in chemical processes. She has authored over 45 publications with strong citation metrics and contributes widely as a reviewer for high-impact journals, guest editor, internal auditor, programme leader, and chair of academic committees. Her work is supported by multiple national and international grants covering carbon capture solvents, porous carbon adsorbents, CO₂ electroreduction, and waste-derived materials. She is an active member of professional bodies including MBOT, IChemE, ACS, and IEM. Her scholarly contributions, leadership roles, and commitment to sustainable engineering highlight her dedication to advancing low-carbon technologies and developing innovative solutions for global climate challenges.

Profile: Google Scholar | ORCID

Featured Publications

Hussin, F., Aroua, M. K., & Daud, W. M. A. W. (2011). Textural characteristics, surface chemistry and activation of bleaching earth: A review. Chemical Engineering Journal, 170(1), 90–106.

Hussin, F., & Aroua, M. K. (2020). Recent trends in the development of adsorption technologies for carbon dioxide capture: A brief literature and patent reviews (2014–2018). Journal of Cleaner Production, 253, 119707.

Hussin, F., Abnisa, F., Issabayeva, G., & Aroua, M. K. (2017). Removal of lead by solar-photovoltaic electrocoagulation using novel perforated zinc electrode. Journal of Cleaner Production, 147, 206–216.

Hussin, F., Hazani, N. N., Khalil, M., & Aroua, M. K. (2023). Environmental life cycle assessment of biomass conversion using hydrothermal technology: A review. Fuel Processing Technology, 246, 107747.

Hussin, F., Aroua, M. K., Kassim, M. A., & Md. Ali, U. F. (2021). Transforming plastic waste into porous carbon for capturing carbon dioxide: A review. Energies, 14(24), 8421.

Solangi, N. H., Hussin, F., Anjum, A., Sabzoi, N., Mazari, S. A., Mubarak, N. M., … (2023). A review of encapsulated ionic liquids for CO₂ capture. Journal of Molecular Liquids, 121266.
(Note: For more than 20 authors I can list first 19 + last; tell me if needed.)

Hussin, F., Aroua, M. K., & Yusoff, R. (2021). Adsorption of CO₂ on palm shell–based activated carbon modified by deep eutectic solvent: Breakthrough adsorption study. Journal of Environmental Chemical Engineering, 9(4), 105333.

Dr. Lexing Li | Cell Biology | Research Excellence Award

Published on 02/12/202512/12/2025 by Life Science

Dr. Lexing Li | Cell Biology | Research Excellence Award

Wuhan University of Bioengineering | China

Dr. Lexing Li is a veterinary biomedical scientist whose work bridges fundamental immunology with practical applications in animal health. He completed his doctoral training in Basic Veterinary Medicine at Huazhong Agricultural University, where he developed strong expertise in macrophage biology, metabolic reprogramming, and autophagy regulation. His research explores how natural compounds—such as Houttuynia cordata and quercetin—modulate inflammation, oxidative stress, and cell-death pathways, contributing to the development of safe, antibiotic-free interventions in livestock production. Dr. Li has published extensively on the CXCL10-CXCR3 axis in tissue repair, the therapeutic potential of targeting FAK and LAMP1, and the role of lncRNAs in autophagy. His work has led to significant insights recognized through competitive research grants, including high-level talent start-up funds and national key laboratory open projects. Before joining academia as a lecturer, he gained five years of industry experience as a Technical Service Director and Product Manager, strengthening his ability to translate research findings into practical solutions for biomedicine and animal husbandry. His ongoing efforts aim to advance immunoregulation, natural-product pharmacology, and host–pathogen interactions, contributing to healthier livestock systems and innovative strategies for combating inflammatory diseases.

Profile: Scopus

Assoc. Prof. Dr. Makoto Inoue | Neuroimmunology | Immunology & Inflammation

Published on 02/12/202512/12/2025 by Life Science

Assoc. Prof. Dr. Makoto Inoue | Neuroimmunology | Immunology & Inflammation

University of Illinois at Urbana-Champaign | United States

Makoto Inoue, Ph.D., is an accomplished neuroimmunologist whose career spans international research and academic leadership across Japan and the United States. He earned his B.S. and M.S. in Pharmacy and Pharmacology before completing his Ph.D. in Neurobiology, establishing a foundation in pain mechanisms and neuropeptide biology. His professional journey includes significant research roles at Nagasaki University, UCLA, Duke University School of Medicine, and the University of Illinois at Urbana-Champaign, where he currently serves as an Associate Professor. His research focuses on neuroimmunology, multiple sclerosis, neuroinflammation, neuropathic pain, early-life trauma effects on immunity, and Cryptococcus-associated immune reconstitution inflammatory syndrome. He has secured numerous competitive grants, contributed extensively to scientific literature, edited journals, and delivered invited talks at leading institutions worldwide. His work has been recognized through multiple prestigious awards, including the Bernard Amos Award, Joy Cappel Young Investigator Award, and the Zoetis Award for Research Excellence. As an active member of global scientific societies and an editorial board member for several journals, he continues to advance understanding of neuroimmune mechanisms. His career highlights his commitment to innovative research, interdisciplinary collaboration, and translating scientific discoveries toward impactful therapies for neurodegenerative and autoimmune diseases.

Profile: Google Scholar

Featured Publications

Gerriets, V. A., Kishton, R. J., Nichols, A. G., Macintyre, A. N., Inoue, M., Ilkayeva, O., … Rathmell, J. C. (2015). Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. The Journal of Clinical Investigation, 125(1), 194–207.

Inoue, M., Rashid, M. H., Fujita, R., Contos, J. J. A., Chun, J., & Ueda, H. (2004). Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nature Medicine, 10(7), 712–718.

Inoue, M., Williams, K. L., Gunn, M. D., & Shinohara, M. L. (2012). NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences, 109(26), 10480–10485.

Michalek, R. D., Gerriets, V. A., Nichols, A. G., Inoue, M., Kazmin, D., Chang, C. Y., … Rathmell, J. C. (2011). Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proceedings of the National Academy of Sciences, 108(45), 18348–18353.

Inoue, M., Williams, K. L., Oliver, T., Vandenabeele, P., Rajan, J. V., Miao, E. A., … Shinohara, M. L. (2012). Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Science Signalling, 5(225), ra38.

Inoue, M., & Shinohara, M. L. (2011). Intracellular osteopontin (iOPN) and immunity. Immunologic Research, 49(1), 160–172.

Ueda, H., Yamaguchi, T., Tokuyama, S., Inoue, M., Nishi, M., & Takeshima, H. (1997). Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neuroscience Letters, 237(2–3), 136–138.

Rongpeng Li | Molecular Biology | Research Excellence Award

Published on 26/11/202526/11/2025 by Life Science

Dr. Rongpeng Li | Molecular Biology | Research Excellence Award

Nantong University | China

Dr. Rongpeng Li is a highly productive researcher whose scientific contributions span molecular microbiology, innate immunity, tumor biology, and therapeutic drug discovery. With a publication record of 60 Scopus-indexed documents, an h-index of 20, and 1541 citations, his work demonstrates sustained impact across both fundamental life science and translational biomedical research. He has led 7 completed or ongoing research projects, in addition to 6 industry-linked consultancy projects, highlighting his strong engagement with applied science. His research focuses on the molecular mechanisms by which the innate immune system recognizes pathogens, regulates virulence, and interacts with host defense pathways, contributing to new insights into immune regulation and pathogen evolution. He has also advanced the understanding of tumor proliferation, resistance mechanisms, CAR-T/CAR-M therapies, and the influence of the tumor and gut microbiome on cancer progression. His contributions to natural drug discovery include identifying new immune-modulating compounds and developing therapeutic vaccine strategies. Notably, his team discovered that TRIM7 promotes NAFLD/NASH progression through DUSP10 degradation, establishing a novel regulatory axis for metabolic liver disease and identifying a promising therapeutic target. With strong publication output, innovation in drug discovery, and leadership in interdisciplinary collaborations, Dr. Li stands as a significant contributor to contemporary life science research.

Profiles: Scopus | Orcid

Featured Publications

Yan, F.-J., Ding, H., Zhang, N., Yan, S.-R., Huang, M.-X., Lu, J.-W., Wang, Y.-J., Yan, Y.-J., Li, R.-P., & Wang, Q. The E3 ligase tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation in male mice.

Wang, Z., Zhao, J., He, S., Li, R., Wang, X., Yan, C., Zhao, J., & Wei, W. Inorganic polyphosphate relieves ulcerative colitis by modulating the gut microbiota and metabolites.

Song, L., Wang, S., Zou, H., Yi, X., Jia, S., Li, R., & Song, J. Regulation of ergosterol biosynthesis in pathogenic fungi: Opportunities for therapeutic development. .

Song, J., Shi, L., Wang, S., Wang, Y., Zhu, Y., Jiang, J., & Li, R. Correction for Song et al., “Acidic/alkaline stress mediates responses to azole drugs and oxidative stress in Aspergillus fumigatus”.

Thibaud Legros | Life Climate and Ecosystem Health | Young Researcher Award

Published on 25/11/2025 by Life Science

Mr. Thibaud Legros | Life Climate and Ecosystem Health | Young Researcher Award

Aix-Marseille University | France

Thibaud Legros is an emerging researcher in chemical ecology whose work focuses on biosphere–atmosphere interactions, soil VOC emissions, and climate-driven changes in Mediterranean forest ecosystems. His publication record includes two scientific publications: one peer-reviewed article on the decline of soil volatile organic compounds in Mediterranean deciduous forests under future drier climates, and one accepted article examining contrasting BVOC emissions from soils in Mediterranean evergreen forests under natural and amplified long-term rain scarcity. While the Scopus reports 2 citation counts and provides 1 h-index, these works represent significant contributions to understanding how drought scenarios influence biogenic emissions and secondary pollutant formation. His research integrates advanced analytical tools such as PTR-MS, GC-MS, and ecophysiological assays, combined with modeling approaches including MEGAN for VOC fluxes and CHIMERE for atmospheric chemistry and transport simulations. His expertise spans soil ecology, plant biology, and multivariate statistical analysis in R, enabling comprehensive assessments of BVOC behavior under climate-induced stressors. Through oral and poster presentations at high-level international conferences, he has demonstrated strong engagement with the global scientific community. With 2 documents, 2 citations reported, and an 1 h-index, his research trajectory shows clear promise and scientific rigor.

Profiles: Scopus | Orcid

Mi-So Jeong | Cancer Biology | Best Researcher Award

Published on 24/11/2025 by Life Science

Dr. Mi-So Jeong | Cancer Biology | Best Researcher Award

Dong-A University | South Korea

Dr. Mi-So Jeong is an active and highly productive cancer biology researcher with a strong publication record centered on bladder cancer genomics, chemoresistance, molecular biomarkers, and tumor progression mechanisms. Her work includes first-author publications in influential journals such as Clinical and Translational Medicine, Cancer Letters, Genes (Basel), Cell Death Discovery, and Genes & Genomics, demonstrating consistent leadership in molecular cancer research. Her studies have identified novel liquid biopsy markers, dissected chemoresistance-associated evolutionary signatures, and clarified genomic variants linked to bladder cancer susceptibility. She has contributed important insights into regulatory pathways involving E2F1, FOXM1, RAD54L, VNTR polymorphisms, CAF-induced migration, and SERPINE1-mediated metastasis, while also participating in multi-institutional programs investigating tumor immunity, molecular repair pathways, and signaling-driven disease recurrence. Her research expands further into breast cancer imaging genomics, hypertension-related VNTR variants, tumor microenvironment regulation, and metastatic signaling. With h-index 8, 18 total documents publications, and 192 citation count citations, together with repeated first-author contributions across high-impact outputs, Mi-So Jeong demonstrates a strong trajectory of scientific advancement.

Profile: Scopus

Featured Publications

Jeong, M. S., Mun, J. Y., Yang, G. E., Baek, S. W., Lee, S. Y., Yun, S. H., Kim, S. I., Kim, J. J., Yoon, S. Y., Nam, J. K., Choi, Y. H., Goh, H. J., Kim, T. N., & Leem, S. H. Lipocalin 2 as a potential liquid biopsy marker for early detection of bladder cancer. Clinical and Translational Medicine.

Jeong, M. S., Baek, S. W., Yang, G. E., Mun, J. Y., Kim, J. A., Kim, T. N., Nam, J. K., Choi, Y. H., Lee, J. S., Chu, I. S., & Leem, S. H. Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Letters, 610, 217339.

Eum, D. Y., Lee, C., Tran, C. S., Lee, J., Park, S. Y., Jeong, M. S., Jin, Y., Shim, J. W., Lee, S. R., Koh, M., Mishchenko, N. P., Park, S. J., Choi, S. H., Choi, Y. J., Yun, H., & Heo, K. (2024). Regulatory role of Echinochrome A in cancer-associated fibroblast-mediated lung cancer cell migration. Toxicological Research, 40(3), 409–419.

Yang, G. E., Kim, M. H., Jeong, M. S., Lee, S. Y., Choi, Y. H., Nam, J. K., Kim, T. N., & Leem, S. H. Association between PDCD6-VNTR polymorphism and urinary cancer susceptibility. Genes & Genomics, 46(11), 1281–1291.

Jeong, M. S., Mun, J. Y., Yang, G. E., Kim, M. H., Lee, S. Y., Choi, Y. H., Kim, H. S., Nam, J. K., Kim, T. N., & Leem, S. H. Exploring the relationship between CLPTM1L-MS2 variants and susceptibility to bladder cancer. Genes, 15(1), 50.

Hailin Meng | Applied Microbiology | Applied Life Science Awards

Published on 24/11/202524/11/2025 by Life Science

Prof. Hailin Meng | Applied Microbiology | Applied Life Science Awards

Guangxi University | China

Professor. Hailin Meng is a leading researcher in synthetic biology and microbiology with an extensive body of work that spans microbial systems modeling, regulatory element engineering, cell factory construction, and probiotic development. His research portfolio includes over 30 academic publications, ranging from high-impact JCR Q1 journals such as Bioresource Technology, Probiotics and Antimicrobial Proteins, Journal of Materials Chemistry A, Journal of Industrial Microbiology & Biotechnology, and Synthetic and Systems Biotechnology, to influential applied studies in microbial ecology, metabolic pathway engineering, and promoter strength prediction. He has also contributed significantly to translational innovation with 6 granted invention patents and 8 granted software copyrights, demonstrating broad expertise from computational design tools to industrial biotechnology applications. His leadership in major scientific projects includes presiding over 3 National Natural Science Foundation of China (NSFC) projects, serving as a key member of a National Key R&D Program, and directing 7 provincial, municipal, and enterprise-funded projects, collectively exceeding ten million RMB in research support. With impactful contributions to microbial synthetic biology and biotechnology innovation, along with an h-index of [insert h-index], [insert total documents] publications, and [insert citation count] citations, Professor Hailin Meng exemplifies the scientific excellence expected of top-tier research recognition.

Profile: Orcid

Featured Publications

Meng, H. (2025). AI-driven discovery and design of antimicrobial peptides: Progress, challenges, and opportunities. Probiotics and Antimicrobial Proteins.

Su, X., Lu, J., Jiang, Y., Liu, F., Zhong, C., Yang, M., Zhang, H., Cui, J., & Meng, H. A synthetic Glutamicibacter consortium efficiently removes ammonium and nitrite from aquaculture wastewater. Bioresource Technology.

Zhong, N., Chen, Y., Pan, W., Meng, H., Liang, K., Lu, J., Jiang, Y., Zhong, C., Yang, M., & Zhai, Y. Integrating metagenomics and high-throughput screening for bioprospecting marine producers of polyhydroxyalkanoates. Letters in Applied Microbiology.

Chen, B., Lin, X., Yang, M., You, Z., Liu, W., Meng, H., Zhou, Y., Yuan, H., & Liao, J. Engineered partially open-cage fluorinated polyhedral oligomeric silsesquioxane hybrid nanoparticle aggregates for surfaces with super-repellency to widespread liquids. Journal of Materials Chemistry A.

Maciej Ryczkowski | Monetary Economics | Research Excellence Award

Published on 22/11/2025 by Life Science

Assoc. Prof. Dr. Maciej Ryczkowski | Monetary Economics | Research Excellence Award

Nicolaus Copernicus University | Poland

Assoc. Prof. Dr. Maciej Ryczkowski is an accomplished researcher whose work spans monetary policy, wavelet-based financial analysis, labor market methodology, and macroeconomic dynamics. His Scopus record has h-index 5, total 52 citation count, and total 12 documents. His scientific achievements include leading major grants funded by Eurostat, the National Science Centre, and Nicolaus Copernicus University, where he developed advanced methodologies for defining labour market areas, studied the interactions between money, credit, and real estate prices, and contributed to large-scale statistical modernization projects. His publications form a coherent and impactful body of work on monetary transmission, quantitative easing, credit cycles, stock price interconnectedness, and macro-financial stability, including award-winning articles recognized by the Polish Economic Society. Dr. Ryczkowski has completed multiple international research stays and has delivered invited lectures and presentations at high-level conferences across Europe. His expertise also extends to practical economic applications, contributing to Eurostat methodologies, national labor market statistics, and the modernization of administrative data systems. He has performed 38 reviews for reputable international journals indexed in JCR and serves as an associate editor for two academic journals. With a strong research portfolio, multiple competitive grants, and internationally recognized publications, he demonstrates clear excellence and is highly suited for recognition such as the Best Researcher Award.

Profile: Scopus | Orcid

Featured Publications

Ryczkowski, M. Zygmunt Narski, Milton Friedman, and modern monetary policy. International Economics and Economic Policy.

Ryczkowski, M., & Zinecker, M. The interconnectedness of stock prices, money, and credit across time and frequency from 1970 to 2016. Technological and Economic Development of Economy.

Ryczkowski, M. Money and inflation in inflation-targeting regimes: New evidence from time–frequency analysis. Journal of Applied Economics.

Ryczkowski, M., & Zinecker, M. Gender unemployment in the Czech and Polish labour market. Argumenta Oeconomica.

Ryczkowski, M. Macroeconomic effects of unconventional balance sheet policies in the United States and the Euro Area. Panoeconomicus

Demokaan Demirel | Life Sciences Innovation | Best Researcher Award

Published on 22/11/202522/11/2025 by Life Science

Assoc. Prof. Dr. Demokaan Demirel | Life Sciences Innovation | Best Researcher Award

Kocaeli University | Turkey

Assoc. Prof. Dr. Demokaan Demirel is a highly productive scholar in public administration, political science, and management sciences, with a strong research portfolio supported by extensive international and national publications. His CV documents 29 international peer-reviewed journal articles, addressing key themes such as smart governance, digital CRM, performance management, e-government, health information systems, ombudsman roles, regionalization, and organizational processes in the digital age. He has also contributed 24 book chapters published by respected academic presses, focusing on strategic management, public policy, sustainability, local governance, administrative modernization, and political economy. Additionally, he has presented over 30 full-text papers at international scientific conferences, demonstrating active engagement with global academic communities. His research spans diverse areas—including digitalization of public services, smart city strategies, customer satisfaction in digital environments, virtual organizations, and historical and contemporary transformations in public administration. Through these contributions, he has significantly advanced scholarly discourse on governance models, administrative reforms, and public-sector innovation. His publication record reflects consistent productivity, interdisciplinary depth, and sustained commitment to knowledge generation, clearly positioning him as a strong candidate for major research recognitions.

Profile: Scopus

Jeongyeon Mun | Molecular Biology | Best Researcher Award

Published on 21/11/2025 by Life Science

Dr. Jeongyeon Mun | Molecular Biology | Best Researcher Award

Columbia University Medical Center | South Korea

Jeong-Yeon Mun is a highly productive researcher whose scientific contributions demonstrate growing global impact, supported by 454 citations recorded in her publication list. Her Google Scholar profile shows an h-index of 17 and 19 peer-reviewed documents, reflecting a consistent record of influential research across cancer genomics, tumor microenvironment biology, and therapeutic resistance mechanisms. Mun’s work spans a diverse collection of studies published in high-visibility journals, where she has contributed as both first author and co-author on investigations addressing critical topics such as glioblastoma metabolism, chemoresistance in bladder cancer, molecular subtype identification, immune regulation, and biomarker discovery. Her research also extends into experimental oncology, employing advanced genomic, metabolic, and molecular techniques to uncover pathways that shape cancer progression and response to therapy. In addition to her publications, she is credited with multiple patents related to diagnostic biomarkers and genetic typing technologies, demonstrating translational relevance beyond academic settings. Mun’s growing citation impact underscores her role in shaping contemporary cancer biology, while her multidisciplinary expertise continues to support significant advancements in understanding tumor behavior, therapeutic vulnerabilities, and molecular disease mechanisms

Profile: Google Scholar

Featured Publications

Mun, J.-Y., Shu, C., Gao, Q., Akman, H. O., Westhoff, M.-A., Karpel-Massler, G., & Siegelin, M. D. CDK12 regulates cellular metabolism to promote therapy resistance in glioblastoma. Cancer Research, 85(8_Supplement_1), 5395–5395.

Jeong, M.-S., Baek, S.-W., Yang, G.-E., Mun, J.-Y., Kim, J.-A., Kim, T.-N., Nam, J.-K., Choi, Y.-H., Lee, J.-S., Chu, I.-S., & Leem, S.-H. Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Letters, 610, 217339.

Leem, S.-H., Mun, J.-Y., Jeong, M.-S., & Kim, M.-H., Yang, G.-E. Novel biomarker for diagnosing and predicting metastasis or prognosis of various cancers, and use (U.S. Patent Application No. 18/573,338).

Nguyen, T. T. T., Gao, Q., Mun, J.-Y., Zhu, Z., Shu, C., Naim, A., Rogava, M., Izar, B., Westhoff, M.-A., Karpel-Massler, G., & Siegelin, M. D. Suppressing PD-L1 expression via AURKA kinase inhibition enhances natural killer cell-mediated cytotoxicity against glioblastoma. Cells, 13(13), 1155.